ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.70
-0.78%
US Tech 100
21,127.60
-0.33%
S&P 500
6,077.11
-0.12%
US Dollar vs CAD
1.41852
0.25%
Bitcoin
101,602.35
0.40%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Generation Bio Company (GBIO)

  7. Generation Bio Company (GBIO) News

GBIO

Generation Bio (GBIO)

Generation Bio Company
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GBIO
DateTimeSourceHeadlineSymbolCompany
11/06/20243:16PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GBIOGeneration Bio Company
11/06/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
11/06/20243:05PMGlobeNewswire Inc.Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial ResultsNASDAQ:GBIOGeneration Bio Company
10/23/20244:04PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:GBIOGeneration Bio Company
10/22/20245:59AMGlobeNewswire Inc.Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual CongressNASDAQ:GBIOGeneration Bio Company
10/17/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
10/17/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
10/17/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
10/17/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
10/17/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
09/12/20243:05PMGlobeNewswire Inc.Generation Bio to Present at the 2024 Cantor Global Healthcare ConferenceNASDAQ:GBIOGeneration Bio Company
08/15/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:GBIOGeneration Bio Company
08/07/20243:31PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:GBIOGeneration Bio Company
08/07/20243:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GBIOGeneration Bio Company
08/07/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
08/07/20243:05PMGlobeNewswire Inc.Generation Bio Reports Second Quarter 2024 Financial ResultsNASDAQ:GBIOGeneration Bio Company
08/06/20245:59AMGlobeNewswire Inc.Generation Bio to Present at the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:GBIOGeneration Bio Company
07/17/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
07/17/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
07/17/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
07/17/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
07/17/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
06/14/20245:59AMGlobeNewswire Inc.Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA SummitNASDAQ:GBIOGeneration Bio Company
06/10/20243:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GBIOGeneration Bio Company
06/07/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
05/13/20243:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GBIOGeneration Bio Company
05/13/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:GBIOGeneration Bio Company
05/13/20243:05PMGlobeNewswire Inc.Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial ResultsNASDAQ:GBIOGeneration Bio Company
05/09/20245:59AMGlobeNewswire Inc.Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual MeetingNASDAQ:GBIOGeneration Bio Company
04/22/20244:31PMGlobeNewswire Inc.Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingNASDAQ:GBIOGeneration Bio Company
 Showing the most relevant articles for your search:NASDAQ:GBIO

Your Recent History

BIT
P1FI07
BNP Paribas Issuance
AQSE
CDGP.GB
Chapel Down
BIT
UC7XF9
Unicredit Bank
BIT
WAAT26
AA Tech
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved